Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas

被引:0
|
作者
Peeter Karihtala
Katja Porvari
Nelli Roininen
Sari Voutilainen
Johanna Mattson
Päivi Heikkilä
Kirsi-Maria Haapasaari
Katri Selander
机构
[1] Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki,Department of Oncology
[2] Oulu University Hospital and University of Oulu,Department of Pathology, Medical Research Center Oulu
[3] Oulu University Hospital and University of Oulu,Department of Oncology and Radiotherapy, Medical Research Center Oulu
[4] University of Helsinki and Helsinki University Hospital,Department of Pathology
来源
Oncogenesis | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The pathophysiology and the optimal treatment of breast neuroendocrine tumours (NETs) are unknown. We compared the mutational profiles of breast NETs (n = 53) with those of 724 publicly available invasive ductal carcinoma (IDC) and 98 pancreatic NET (PNET) cases. The only significantly different pathogenetic or unknown variant rate between breast NETs and IDCs was detected in the TP53 (11.3% in breast NETs and 41% in IDCs, adjusted p value 0.027) and ADCK2 (9.4% in breast NETs vs. 0.28% in IDCs, adjusted p value 0.045) genes. Between breast NETs and PNETs, different pathogenetic or unknown variant frequencies were detected in 30 genes. For example, MEN1 was mutated in only 6% of breast NETs and 37% in PNETs (adjusted p value 0.00050), and GATA3 pathogenetic or unknown variants were only found in 17.0% of breast NETs and 0% in PNETs (adjusted p value 0.0010). The most commonly affected oncogenic pathways in the breast NET cases were PI3K/Akt/mTOR, NOTCH and RTK-RAS pathways. Breast NETs had typically clock-like mutational signatures and signatures associated with defective DNA mismatch repair in their mutational landscape. Our results suggest that the breast NET mutational profile more closely resembles that of IDCs than that of PNETs. These results also revealed several potentially druggable targets, such as MMRd, in breast NETs. In conclusion, breast NETs are indeed a separate breast cancer entity, but their optimal treatment remains to be elucidated.
引用
收藏
相关论文
共 50 条
  • [21] Neuroendocrine Carcinomas Pancreatic Origin, Polish Experience
    Kolasinska-Cwikla, A.
    Lewczuk, A.
    Cichocki, A.
    Roszkowska-Purska, K.
    Maciejkiewicz, K.
    Nowicka, E.
    Tenderenda, M.
    Cwikla, J.
    NEUROENDOCRINOLOGY, 2017, 105 : 85 - 85
  • [22] Histopathological and Clinical Differences Between Primary Breast Carcinomas With Neuroendocrine Features and Primary Breast Carcinomas Mimicking Neuroendocrine Features
    Talu, Canan Kelten
    Savli, Taha Cumhan
    Huq, Gulben Erdem
    Leblebici, Cem
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2019, 27 (07) : 744 - 752
  • [23] The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas
    Rizvi, Selim M. H.
    Goodwill, Joseph
    Lim, Eric
    Yap, Yoong K.
    Wells, Athol U.
    Hansell, David M.
    Davis, Peter
    Abdel-Ghani, Syed
    Goldstraw, Peter
    Nicholson, Andrew G.
    HISTOPATHOLOGY, 2009, 55 (03) : 332 - 337
  • [24] Comparison of Metastatic Patterns Among Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Nonneuroendocrine Carcinomas of Various Primary Organs
    Park, Hyung Kyu
    Kwon, Ghee Young
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (11)
  • [25] The genetic landscape of breast carcinomas with neuroendocrine differentiation
    Marchio, Caterina
    Geyer, Felipe C.
    Ng, Charlotte K. Y.
    Piscuoglio, Salvatore
    De Filippo, Maria R.
    Cupo, Marco
    Schultheis, Anne M.
    Lim, Raymond S.
    Burke, Kathleen A.
    Guerini-Rocco, Elena
    Papotti, Mauro
    Norton, Larry
    Sapino, Anna
    Weigelt, Britta
    Reis-Filho, Jorge S.
    JOURNAL OF PATHOLOGY, 2017, 241 (03): : 405 - 419
  • [26] ULTRASTRUCTURAL FEATURES OF NEUROENDOCRINE DIFFERENTIATED CARCINOMAS OF THE BREAST
    CAPELLA, C
    USELLINI, L
    PAPOTTI, M
    MACRI, L
    FINZI, G
    EUSEBI, V
    BUSSOLATI, G
    ULTRASTRUCTURAL PATHOLOGY, 1990, 14 (04) : 321 - 334
  • [27] Neuroendocrine differentiated carcinomas of the breast:: a distinct entity
    Zekioglu, O
    Erhan, Y
    Çiris, M
    Bayramoglu, H
    BREAST, 2003, 12 (04): : 251 - 257
  • [28] Clinicopathological features of neuroendocrine carcinomas (NECs) of the breast
    La Rosa, S.
    Casnedi, S.
    Riva, C.
    Sessa, F.
    Capella, C.
    LABORATORY INVESTIGATION, 2007, 87 : 39A - 39A
  • [29] Biomarkers of Targeted Treatment in Neuroendocrine Breast Carcinomas
    Gatalica, Zoran
    Palazzo, Juan
    Sanati, Souzan
    Florento, Elena T.
    Xiu, Joanne
    Swensen, Jeffrey
    Vranic, Semir
    LABORATORY INVESTIGATION, 2018, 98 : 61 - 61
  • [30] Clinicopathological features of neuroendocrine carcinomas (NECs) of the breast
    La Rosa, S.
    Casnedi, S.
    Riva, C.
    Sessa, F.
    Capella, C.
    MODERN PATHOLOGY, 2007, 20 : 39A - 39A